Literature DB >> 90612

Identification and characterisation of the major antiproteases in equine serum and an investigation of their role in the onset of chronic obstructive pulmonary disease (COPD).

A G Matthews.   

Abstract

Three major antiprotease components in equine serum were identified and characterised. These were the acidic prealbumin Pr, the homologue of human alpha-1 antitrypsin and 2 protease binding proteins, the acidic prealbumin Xc and alpha-2 macroglobulin, both capable of inhibiting the proteolytic activity of trypsin, but with only limited inhibitory effect on its esterolytic activity. The possible role of these serum antiproteases in the onset of chronic obstructive pulmonary disease (COPD), analogous to the hereditary dysproteinaemia of alpha-1 antitrypsin in man, was investigated. There was no evidence of a genetically determined variation in the protease binding proteins but an increased frequency of the electrophoretically slower Pr antitrypsin alleles was present in horses affected with COPD. However, because of both the mixed breeding of the animals investigated and the lack of correlation with low serum trypsin inhibitory capacity, measured by inhibition of DL-BAPA hydrolysis, the significance of this observation could not be critically assessed.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 90612     DOI: 10.1111/j.2042-3306.1979.tb01336.x

Source DB:  PubMed          Journal:  Equine Vet J        ISSN: 0425-1644            Impact factor:   2.888


  3 in total

1.  Quantitative comparisons of acidic prealbumin (PR) phenotypes in horses.

Authors:  N Ek; M Braend
Journal:  Acta Vet Scand       Date:  1980       Impact factor: 1.695

2.  A study of the interaction between bromocresol green dye and bovine, ovine and equine serum globulins.

Authors:  G Keay; D L Doxey
Journal:  Vet Res Commun       Date:  1984-02       Impact factor: 2.459

3.  Spi2 gene polymorphism is not associated with recurrent airway obstruction and inflammatory airway disease in thoroughbred horses.

Authors:  Aline Correa da Silva; Karin Erica Brass; Elgion da Silva Loreto; Myriam Elizabeth Vinocur; Ricardo Pozzobon; Marcos da Silva Azevedo
Journal:  Genet Mol Biol       Date:  2011-07-01       Impact factor: 1.771

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.